Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.65 USD | +1.39% | -4.70% | -73.95% |
May. 09 | Earnings Flash (GNLX) GENELUX CORPORATION Reports Q1 Revenue $8,000 | MT |
May. 09 | Genelux Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 23
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Diagnostic and Therapeutic Solutions
100.0
%
| 11 | 100.0 % | 0 | 100.0 % | -98.46% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 11 | 100.0 % | 0 | 100.0 % | -98.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Zindrick
CEO | Chief Executive Officer | 65 | 09-12-31 |
Lourie Zak
DFI | Director of Finance/CFO | 61 | 23-08-27 |
Paul Scigalla
CTO | Chief Tech/Sci/R&D Officer | 79 | 11-08-31 |
Joseph Cappello
CTO | Chief Tech/Sci/R&D Officer | 67 | 12-10-31 |
Caroline Jewett
PRN | Corporate Officer/Principal | 59 | 23-07-19 |
Sean Ryder
LAW | General Counsel | 54 | 21-09-30 |
Qian Zhang
PRN | Corporate Officer/Principal | 60 | 02-12-31 |
Tony Yu
PRN | Corporate Officer/Principal | 53 | 01-12-31 |
Ralph Smalling
LAW | General Counsel | 68 | 23-07-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Tyree
BRD | Director/Board Member | 71 | 12-05-01 |
John Thomas
BRD | Director/Board Member | 66 | 02-08-31 |
John Smither
BRD | Director/Board Member | 71 | 23-09-10 |
Thomas Zindrick
CEO | Chief Executive Officer | 65 | 09-12-31 |
Mary Mirabelli
BRD | Director/Board Member | 67 | 21-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 27,430,073 | 21,063,205 ( 76.79 %) | 433,333 ( 1.580 %) | 76.79 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-73.95% | 96.96M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- GNLX Stock
- Company Genelux Corporation